Virtual Event Coverage

Investor Summit Group Q3 Virtual Conference

August 17-18, 2021 - Virtual Event
Investor Summit Group Q3 Virtual Conference

Investor Summit Group's events feature live presentations with Q&A, 1 on 1 meetings, roundtables, workshops, fireside chats and more. Each quarterly summit provides the opportunity to discuss relevant topics in the investment space with quality vetted investors and handpicked executives. With countless interaction possibilities, attendees are brought as close as possible with Investor Summit Group's next-generation networking platform.

For more information visit:
Conference Website

01 Communique Laboratory Inc. (TSX.V: ONE) (OTCQB: OONEF)

01 Communique Laboratory Inc. (TSX.V: ONE) (OTCQB: OONEF), established in 1992, operates at the forefront of technology. The company's cyber security business unit focuses on post-quantum cybersecurity with the development of its IronCAP™ technology. IronCAP's patent-pending cryptographic system is an advanced Goppa code-based post-quantum cryptographic technology that can be implemented on classical computer systems while at the same time safeguarding against attacks in the future post-quantum world of computing. The company's remote access business unit provides its customers with a suite of secure remote access services and products under its 'I'm InTouch' and 'I'm OnCall' product offerings. For more information, visit the company's website at

Adcore Inc. (TSX: ADCO) (OTCQX: ADCOF)

Adcore Inc. (TSX: ADCO) (OTCQX: ADCOF) is empowering entrepreneurs, advertisers and the future of e-commerce through its advertising management and automation platform. By combining extensive industry knowledge and experience with its proprietary artificial intelligence engine, Adcore offers a unique digital marketing solution that empowers entrepreneurs and advertisers by managing and automating their e-commerce store advertising and monitoring and analyzing the performance of their advertising budget to ensure maximum return on investment. In addition to being named numerous times on Deloitte's Fast 50 Technology list, Adcore is a certified Google Premier Partner, Microsoft Partner, Facebook Partner and TikTok Partner. For more information, visit the company's website at

AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI)

AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) is an agriculture-focused technology company that develops and acquires intellectual property systems that are intended to deliver innovative, reliable and financially robust solutions for high-value crops through its proprietary facility design and automation intellectual property to businesses and enterprises. The company intends to operate in the plant-based pharmaceutical, nutraceutical and other high-value crop markets using its unique proprietary facility design and hydroponics-based automated growing system that enable cultivators to effectively grow crops in a controlled environment. The company calls its facility design and automated growing system the "AgriFORCE grow house." The company has designed its AgriFORCE grow house to produce in virtually any environmental condition and to optimize crop yields to as near their full genetic potential possible, while substantially eliminating the need for the use of pesticides and/or irradiation. For more information, visit the company's website at

Amesite Inc. (NASDAQ: AMST)

Amesite Inc. (NASDAQ: AMST) is a high-tech artificial intelligence software company offering a cloud-based platform and content creation services for business, university and K-12 learning and upskilling. With Amesite, learning is more affordable, accessible and engaging. The company's team helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI. Amesite-offered courses and programs are branded to its customers. For more information, visit the company's website at

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC)

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) is a biotechnology company focused on early cancer screening and detection, with 142 issued patents as of March 31, 2021. With two certified clinical laboratories in China and one CLIA registered clinical laboratory in the United States, AnPac Bio performs a suite of cancer screening and detection tests, including CDA (Cancer Differentiation Analysis), bio-chemical, immunological and genomics tests. According to Frost & Sullivan, AnPac Bio ranked third worldwide among companies offering next-generation early cancer screening and detection technologies in terms of the number of clinical samples for cancer screening and detection, based on approximately 41,700 clinical samples as of December 31, 2019. AnPac Bio's CDA technology platform has been shown in retrospective validation studies to be able to detect the risk of over 20 different cancer types with high sensitivity and specificity. For more information, visit the company's website at

ARC Document Solutions Inc. (NYSE: ARC)

ARC Document Solutions Inc. (NYSE: ARC) provides a wide variety of document distribution and graphic production services to facilitate communication for professionals in the design, marketing, commercial real estate, construction and related fields. From hospitals and universities to restaurants, hotels and AEC companies, the company provides print and document management solutions for all industries and deliver remarkable results every step of the way, including a full spectrum of printing solutions such as wall graphics, event displays, tradeshow booths, banners, signs, retail graphics, marketing materials, and car wraps. For more information, visit the company's website at

ARCA biopharma Inc. (NASDAQ: ABIO)

ARCA biopharma Inc. (NASDAQ: ABIO) is dedicated to developing genetically targeted therapies for cardiovascular diseases through a precision medicine approach to drug development. ARCA is developing rNAPc2 as a potential treatment for diseases caused by RNA viruses, initially focusing on COVID-19. The U.S. FDA has granted Fast Track designation to the rNAPc2 development program, currently in Phase 2b clinical testing and an Orphan Drug designation for the use of rNAPc2 for the treatment of Ebola. ARCA is also developing Gencaro™ (bucindolol hydrochloride), an investigational, pharmacologically unique beta-blocker and mild vasodilator, as a potential treatment for atrial fibrillation in heart failure patients. ARCA has identified common genetic variations that it believes predict individual patient response to Gencaro, giving it the potential to be the first genetically targeted AF prevention treatment. For more information, visit the company's website at

Artelo Biosciences Inc. (NASDAQ: ARTL)

Artelo Biosciences Inc. (NASDAQ: ARTL) is a biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting the endocannabinoid system and related biological signaling pathways. Artelo is applying true biopharma discipline toward rapidly advancing a diverse portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, pain and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the company applies leading edge scientific, regulatory and commercial discipline to develop high-impact therapies. For more information, visit the company's website at

Assure Holdings Corp. (OTCQB: ARHH) (TSX.V: IOM)

Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring (IONM) activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. In the first quarter of 2021, Assure complemented its core business by launching a telehealth offering for professional neurology services relating to IONM. The Company is recognized as providing the highest level of patient care in the industry and has earned the Joint Commission's Gold Seal of Approval®. For more information, visit the company's website at


AYRO Inc. (NASDAQ: AYRO) engineers and manufactures purpose-built electric vehicles to enable sustainable fleets. With rapid, customizable deployments that meet specific buyer needs, AYRO's agile EVs are an eco-friendly microdistribution alternative to gasoline vehicles. The AYRO Club Car Current is the only zero-emission, light-duty EV known to AYRO that can be optimized for the needs of any sustainable fleet. AYRO innovates with speed, discipline, and agility and was founded in 2017 by entrepreneurs, investors, and executives with a passion for creating sustainable urban electric vehicle solutions for micromobility. For more information, visit the company's website at

Ballantyne Strong Inc. (NYSE American: BTN)

Ballantyne Strong Inc. (NYSE American: BTN) is a diversified holding company with operations and holdings across a broad range of industries. The company's Strong Entertainment segment includes the largest premium screen supplier in the U.S. and also provides technical support services and other related products and services to the cinema exhibition industry, theme parks and other entertainment-related markets. Ballantyne Strong holds a $13 million preferred stake along with Google Ventures in privately held Firefly Systems Inc., which is rolling out a digital mobile advertising network on rideshare and taxi fleets. Finally, the company holds an approximately 19% ownership position in GreenFirst, and an approximately 21% ownership position in FG Financial Group Inc. (NASDAQ: FGF), a reinsurance and investment management holding company focused on opportunistic collateralized and loss capped reinsurance, while allocating capital to SPAC and SPAC sponsor-related businesses. For more information, visit the company's website at

Banxa Holdings Inc. (TSX.V: BNXA) (OTCQX: BNXAF)

Banxa Holdings Inc. is a Payment Service Provider (PSP) with a mission to build the bridge between traditional financial systems, regulation and the digital asset space. Our goal is to onboard the general public to digital currency by building a fully compliant payment infrastructure that enables simple and secure conversion of fiat currency to digital currency (eg. USD/CAD to BTC/ETH). Banxa has offices in Australia, the Netherlands and Lithuania and operations in Canada and the EU. For more information, visit the company's website at

BioCardia Inc. (NASDAQ: BCDA)

BioCardia Inc. (NASDAQ: BCDA), headquartered in San Carlos, California, is developing regenerative biologic therapies to treat cardiovascular and pulmonary disease. CardiAMP™ autologous and NK1R+ allogeneic cell therapies are the company's biotherapeutic product candidates in clinical development. The company's current products include the Helix™ transendocardial delivery system, the Morph® steerable guide and sheath catheter portfolio and the AVANCE™ steerable introducer family. BioCardia also partners with other biotherapeutic companies to provide its Helix systems and development support to their programs studying therapies for the treatment of heart failure, chronic myocardial ischemia and acute myocardial infarction. For more information, visit the company's website at

Bitfarms Ltd. (TSX.V: BITF) (OTC: BFARF)

Bitfarms Ltd. (TSX.V: BITF) (OTC: BFARF) is a Bitcoin mining company, running vertically integrated mining operations with onsite technical repair, proprietary data analytics and company-owned electrical engineering and installation services to deliver high operational performance and uptime. Bitfarms has a diversified production platform with five industrial scale facilities located in Québec. Each facility is 100% powered with environmentally friendly hydro power and secured with long-term power contracts. For more information, visit the company's website at

Braemar Hotels & Resorts Inc. (NYSE: BHR)

Braemar Hotels & Resorts Inc. (NYSE: BHR) is a real estate investment trust (REIT) focused on investing in luxury hotels and resorts. Its portfolio primarily consists of high RevPAR, full-service luxury hotels and resorts. In August 2021, the company announced its completion of the acquisition of the 138-room Mr. C Beverly Hills Hotel in Los Angeles, California, as well as five luxury condominium residences adjacent to the hotel, for total consideration of $77.9 million. For more information, visit the company's website at

BriaCell Therapeutics Corp. (NASDAQ: BCTX) (TSX.V: BCT)

BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX-V:BCT) is a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer. BriaCell achieved positive proof-of-concept in a Phase I/IIa clinical trial for Bria-IMT™ in patients with advanced breast cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT™ in a combination with retifanlimab and epacadostat (both provided by Incyte under a collaboration agreement). Additionally, BriaCell is developing Bria-OTS™, the first "off the shelf" personalized immunotherapy for advanced breast cancer. For more information, visit the company's website at

C-COM Satellite Systems Inc. (TSXV: CMI) (OTCQB: CYSNF)

C-COM Satellite Systems Inc. is an innovator and leading global provider of mobile on the pause satellite-based antenna systems. The Company designs, develops and manufactures proprietary, auto-acquisition antenna systems for rapid antenna pointing to a satellite, with just the press of a button. This technology makes it possible to deliver, Broadband Internet via Satellite across a wide range of market applications worldwide, including regions unserved or underserved by terrestrial access technologies. C-COM has sold more than 8,500 antenna systems, in over 100 countries, through a dedicated dealer network that provides service to a wide range of vertical markets such as Oil & Gas Exploration, Military Communications, Disaster Management, SNG, Emergency Communications, Cellular Backhaul, Telemedicine, Mobile Education, Government Services, Mobile Banking, and others. The Company's iNetVu® brand is synonymous with high quality, reliability, and cost-effectiveness. C-COM is in late-stage development of a potentially revolutionary Ka-band, electronically steerable, modular, conformal, flat panel phased array antenna. In cooperation with the University of Waterloo, C-COM is engaged in the design of this unique antenna with the intent of providing low-cost, high-throughput mobility applications over satellite for land, airborne and maritime verticals. For more information, visit the company's website at

Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF)

Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) is a premier consumer-driven cannabis company specializing in production, processing, wholesale, distribution and retail, with 12 dispensaries in Portland, Oregon. The company is committed to developing a dynamic portfolio built around the recognized brands of Chalice Farms, with a focus on health and wellness. Chalice operates nationally through Fifth & Root and has operations in Oregon and California. For more information, visit the company's website at

Charge Enterprises Inc. (OTC: CRGE)

Charge Enterprises Inc. (OTC: CRGE) has a mission of connecting people everywhere with a strategy that incorporates telecom network infrastructure, connected calls, power banks and charging for electric vehicles. Trading on the OTC with an application recently submitted to the Nasdaq for uplisting, Charge Enterprises is a public company that shares its success with all stakeholders. The company operates in three distinct divisions through a number of recently acquired, or newly formed subsidiaries, including Charge Communications, Chare Infrastructure, Charge Investment and ANS Advanced Network Services. The management team is focused on the unglamorous part of connecting calls and powering the future of movement. For more information, visit the company's website at

Cryo-Cell International Inc. (OTC: CCEL)

Cryo-Cell International Inc. (OTC: CCEL) is the world's first private cord blood bank. More than 500,000 parents from 87 countries have entrusted Cryo-Cell International with their baby's cord blood and cord tissue stem cells. In addition to its private bank, Cryo-Cell International has a public banking program in partnership with Duke University. Cryo-Cell's public bank has provided cord blood for more than 600 transplantations and operates cord blood donation sites across the U.S in prominent hospitals such as Cedars–Sinai Hospital in Los Angeles and Baptist Hospital in Miami. Cryo-Cell's facility is FDA registered, cGMP-/cGTP-compliant and licensed in all states requiring licensure. For more information, visit the company's website at

Datasea Inc. (NASDAQ: DTSS)

Datasea Inc. (NASDAQ: DTSS) is a technology company in China engaged in providing smart security solutions, smart hardware and developing education-related technologies. Datasea leverages its proprietary technologies, intellectual property, innovative products and market intelligence to provide comprehensive and optimized security solutions and education related technologies to its clients. Datasea has been certified as one of the High Tech Enterprises (jointly issued by the Beijing Science and Technology Commission, Beijing Finance Bureau, Beijing State Taxation Bureau and Beijing Local Taxation Bureau) and one of the Zhongguancun High Tech Enterprises (issued by the Zhongguancun Science Park Administrative Committee) in recognition of the company's achievement in high technology products. For more information, visit the company's website at

DMG Blockchain Solutions Inc. (TSX.V: DMGI) (OTCQB: DMGGF)

DMG Blockchain Solutions Inc. (TSX.V: DMGI) (OTCQB: DMGGF) is an environmentally friendly vertically integrated blockchain and cryptocurrency company that manages, operates, and develops end-to-end digital solutions to monetize the blockchain ecosystem. DMG's sustainable businesses are segmented into three main divisions: data center operations, data analytics, and forensics, and developing enterprise blockchains. DMG's non-polluting data center operations focus on earning eco-friendly revenues from block rewards and transaction fees by mining primarily bitcoin as well as providing hosting services for industrial mining clients entirely powered by renewable energy. DMG's data analytics and forensic services provide software products such as Blockseer Pool, Mine Manager, and Walletscore, as well as working with auditors, law firms, and law enforcement organizations. DMG's permissioned blockchain technology is focused on developing enterprise software for the supply chain management of controlled products. DMG's strategy is to become the domain experts across the business verticals it focuses on. DMG's environmentally committed management team includes seasoned crypto experts, forensic & financial professionals, and blockchain developers with deep relationships throughout the industry and a strong ecological consciousness. For more information, visit the company's website at

Esports Entertainment Group Inc. (NASDAQ: GMBL)

Esports Entertainment Group Inc. (NASDAQ: GMBL) is a full stack esports and online gambling company fueled by the growth of video-gaming and the ascendance of esports with new generations. Our mission is to help connect the world at large with the future of sports entertainment in unique and enriching ways that bring fans and gamers together. Esports Entertainment Group and its affiliates are well-poised to help fans and players to stay connected and involved with their favorite esports. From traditional sports partnerships with professional NFL/NHL/NBA/FIFA teams, community-focused tournaments in a wide range of esports, and boots-on-the-ground LAN cafes, EEG has influence over the full-spectrum of esports and gaming at all levels. The Company maintains offices in New Jersey, the UK and Malta. For more information, visit the company's website at

FansUnite Entertainment Inc. (CSE: FANS) (OTCQX: FUNFF)

FansUnite Entertainment Inc. (CSE: FANS) (OTCQX: FUNFF) is a global sports and entertainment company, focusing on technology related to regulated and lawful online gaming and other related products. FansUnite has produced a one-of-a-kind complete iGaming platform, with a sports and esports focus geared for the next generation of online bettors and casino players. The platform includes products for pre-match betting, in-play betting, daily fantasy, content and a certified RNG to produce casino style chance games. The platform operates multiple B2C brands and B2B software for the online gambling industry. FansUnite also looks to acquire technology platforms and assets with high growth potential in new or developing markets. For more information, visit the company's website at

FLYHT Aerospace Solutions Ltd. (TSX.V: FLY) (OTCQX: FLYLF)

FLYHT Aerospace Solutions Ltd. (TSX.V: FLY) (OTCQX: FLYLF) provides airlines with actionable intelligence to transform operational insight into immediate, quantifiable action, delivering industry-leading solutions to improve aviation safety, efficiency and profitability. This unique capability is driven by FLYHT's patented aircraft-certified hardware products, including AFIRS, a satcom aircraft interface device which enables real-time streaming of flight information, cockpit voice and black box data streaming, and TAMDAR, which aggregates and streams airborne weather data in real-time. FLYHT is an AS9100 Quality registered company. For more information, visit the company's website at

GameOn Entertainment Technologies Inc. (CSE: GET)

GameOn Entertainment Technologies (CSE: GET) is the leading technology company providing consumers, broadcasters, sportsbooks, venues and brand partners with interactive, social experiences around sports, television and live events. After completing the Comcast NBCUniversal LIFT Labs Accelerator, powered by Techstars in 2018, GameOn has secured distribution and white label projects with several partners. V2 Games Inc. completed the asset purchase of GameOn in December 2020. For more information, visit the company's website at

Genco Shipping & Trading Ltd. (NYSE: GNK)

Genco Shipping & Trading Ltd. (NYSE: GNK) is a U.S. based drybulk ship owning company focused on the seaborne transportation of commodities globally. Genco provides a full-service logistics solution to its customers utilizing its in-house commercial operating platform, as the company transports key cargoes such as iron ore, grain, steel products, bauxite, cement, nickel ore and other commodities along worldwide shipping routes. Genco's wholly owned high quality, modern fleet of dry cargo vessels consists of the larger Capesize (major bulk) and the medium sized Ultramax and Supramax vessels (minor bulk) enabling the company to carry a wide range of cargoes. As of August 4, 2021, Genco Shipping & Trading Limited's fleet consists of 17 Capesize, nine Ultramax and 13 Supramax vessels with an aggregate capacity of approximately 4,314,000 dwt and an average age of 10.6 years. For more information, visit the company's website at

Hanjiao Group Inc. (OTC: HJGP)

Hanjiao Group Inc. (OTC: HJGP) is a Nevada corporation engaged in the business of distributing health care and other related products to the middle-aged and elderly market segments in the People's Republic of China through its online e-commerce platform and offline service centers. Hanjiao's business is conducted through Beijing Luji Technology Co. Ltd., a variable interest entity formed in Beijing, China, on March 27, 2007. For more information, visit the company's website at

Harbor Custom Development Inc. (NASDAQ: HCDI)

Harbor Custom Development Inc. (NASDAQ: HCDI) is a real estate development company involved in all aspects of the land development cycle including land acquisition, entitlements, construction of project infrastructure, home building, marketing, sales, and management of various residential projects in Western Washington's Puget Sound region; Sacramento, California; and Austin, Texas. Harbor has active or recently sold-out residential communities in Gig Harbor, Bremerton, Silverdale, Bainbridge Island, Belfair, Allyn, Port Orchard, and Blaine in the state of Washington. In addition, Harbor has acquired land and will begin constructing homes in three new markets. In the Sacramento metro market, Harbor will be constructing homes in completed subdivisions in both Rocklin and Auburn, California. In the Austin metro market, Harbor has acquired developed lot inventory in Dripping Springs, Driftwood and Horseshoe Bay, Texas. The company has recently acquired property in Punta Gorda, Florida, and plans to begin construction of oceanfront condominiums there in 2022. For more information, visit the company's website at

HAVN Life Sciences Inc. (CSE: HAVN)

HAVN Life Sciences Inc. (CSE: HAVN) is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products and innovative therapies to support brain health and enhance the capabilities of the mind. Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of standardized, naturally derived psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, HAVN Life offers a full range of high-quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle. For more information, visit the company's website at

Helius Medical Technologies Inc. (NASDAQ: HSDT) (TSX: HSM)

Helius Medical Technologies Inc. (NASDAQ: HSDT) (TSX: HSM) is a neurotech company in the medical device industry that is focused on neurological wellness. The company's purpose is to develop, license and acquire unique and noninvasive platform technologies that amplify the brain's ability to heal itself. The company's first commercial product is the Portable Neuromodulation Stimulator (PoNS(TM)). For more information, visit the company's website at

Ideal Power Inc. (NASDAQ: IPWR)

Ideal Power Inc. (NASDAQ: IPWR) is pioneering the development of its broadly patented bi-directional power switches, creating highly efficient and eco-friendly energy control solutions for industrial, alternative energy, military and automotive applications. The company is focused on its patented bi-directional, bi-polar junction transistor (B-TRAN(TM)) semiconductor technology. B-TRAN is a unique double-sided bi-directional AC switch that's able to deliver substantial performance improvements over today's conventional power semiconductors. Ideal Power believes B-TRAN modules will reduce conduction and switching losses, complexity of thermal management and operating cost in medium-voltage AC power switching and control circuitry. For more information, visit the company's website at

International Land Alliance Inc. (OTCQB: ILAL)

International Land Alliance Inc. (OTCQB: ILAL) is an international land investment and development firm based in San Diego, California. As its core mission, the company has embraced technology for sustainable and socially responsible solutions, in addition to using proptech and construction tech advanced applications to meet these goals. The company is focused on acquiring attractive raw land primarily in Northern Baja California, often within driving distance from Southern California. The company serves its shareholders by devoting considerable time and resources to seeking out the finest sites available and obtaining the necessary development permits to build a compelling portfolio of properties, which provide a diversity of investment and living options. For more information, visit the company's website at

Khiron Life Sciences Corp. (TSX.V: KHRN) (OTCQX: KHRNF)

Khiron Life Sciences Corp. (TSX.V: KHRN) (OTCQX: KHRNF) is a vertically integrated medical and CPG cannabis company with core operations in Latin America and operational activity in Europe and North America. Khiron is the leading medical cannabis provider in Colombia and the first company licensed in Colombia for the cultivation, production, domestic distribution and sales, and international export of both low- and high-THC medical cannabis products. The company has filled medical cannabis prescriptions in Colombia, Peru and the UK, and it is positioned to commence sales of medical cannabis in Germany and Brazil. For more information, visit the company's website at

Kintara Therapeutics Inc. (NASDAQ: KTRA)

Kintara Therapeutics Inc. (NASDAQ: KTRA) is dedicated to the development of novel cancer therapies for patients with rare unmet medical needs. Kintara is currently developing two Phase 3-ready therapeutics, VAL-083 for glioblastoma multiforme (GBM) and REM-001 for cutaneous metastatic breast cancer (CMBC). VAL-083 is a first-in-class, small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including central nervous system, ovarian and other solid tumors (e.g., NSCLC, bladder cancer, head and neck) in U.S. clinical trials sponsored by the National Cancer Institute (NCI). REM-001 is a proprietary, late-stage photodynamic therapy platform that holds promise as a localized cutaneous, or visceral, tumor treatment as well as in other potential indications. For more information, visit the company's website at


KORE Mining Ltd. (TSX.V: KORE) (OTCQX: KOREF) is 100% owner of the Imperial and Long Valley gold projects in California. Both projects have positive preliminary economic assessments. KORE is supported by strategic investor Eric Sprott, who owns 26% of KORE's basic shares. KORE's management and board are aligned with shareholders, owning an additional 35% of the basic shares outstanding. KORE is actively advancing its Imperial Gold project and is aggressively exploring across its portfolio of assets. For more information, visit the company's website at

Leaf Mobile Inc. (TSX.V: LEAF) (OTC: LEMLF)

Leaf Mobile Inc. (TSX.V: LEAF) (OTC: LEMLF) is a leading free-to-play mobile game group, creating engaging games that produce enduring player loyalty. Its studio group's entrepreneurial culture is anchored in creativity, execution and growth through a diverse portfolio of original and licensed IP mobile games that include: Archer: Danger Phone, Bud Farm Idle Tycoon, Cheech & Chong Bud Farm, The Goldbergs: Back to the 80s, It's Always Sunny: The Gang Goes Mobile, Trailer Park Boys Grea$y Money, and the soon to be released RuPaul's Drag Race Mobile Game. Leaf Mobile is headquartered in Vancouver, Canada, and its games are available worldwide on the App Store and Google Play. For more information, visit the company's website at

Lightwave Logic Inc. (OTCQX: LWLG)

Lightwave Logic Inc. (OTCQX: LWLG) is a U.S.-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform, which uses in-house proprietary high-activity and high-stability organic polymers. The company is developing a platform leveraging its proprietary engineered electro-optic (EO) polymers to transmit data at higher speeds with less power. The company's high-activity and high-stability organic polymers allow Lightwave Logic to create next-generation photonic EO devices, which convert data from electrical signals into optical signals, for applications in data communications and telecommunications markets. For more information, visit the company's website at

Manitex International Inc. (NASDAQ: MNTX)

Manitex International Inc. (NASDAQ: MNTX) is a leading worldwide provider of highly engineered mobile cranes (truck mounted straight-mast and knuckle boom cranes, industrial cranes, rough terrain cranes and railroad cranes), truck mounted aerial work platforms and specialized industrial equipment. The company's products, which are manufactured in facilities located in the U.S. and Europe, are targeted to selected niche markets where their unique designs and engineering excellence fill the needs of customers and provide a competitive advantage. Manitex has consistently added to its portfolio of branded products and equipment, both through internal development and focused acquisitions to diversify and expand the sales and profit base while remaining committed to the company's niche market strategy. Brands include Manitex, PM, Oil & Steel, Badger, MAC, PM Tadano, and Valla. For more information, visit the company's website at

Midwest Energy Emissions Corp. (OTCQB: MEEC)

Midwest Energy Emissions Corp. (OTCQB: MEEC) is a leading environmental technologies company developing and delivering patented and proprietary solutions to the global power industry. ME2C's leading-edge services have been shown to achieve emissions removal at a significantly lower cost and with less operational impact than currently used methods, while maintaining and/or increasing power plant output and preserving the marketability of byproducts for beneficial use. For more information, visit the company's website at

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH)

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) is a life sciences company focused on innovating and commercializing new ways to promote healing and improve mental health. The company is developing digital therapeutics technology and researching psychedelic compounds to support access to safe, evidence-based psychedelic-assisted therapies globally. For more information, visit the company's website at

Mitesco Inc. (OTCQB: MITI)

Mitesco Inc. (OTCQB: MITI), through wholly owned subsidiary The Good Clinic LLC, plans to build out a network of clinics using the latest telehealth technology with the nurse practitioner operating as its primary health care provider. It will begin in Minneapolis and plans to expand nationwide. Today, 23 states facilitate nurse practitioners practicing to the full scope of their skills and training. The executive team at The Good Clinic includes several of the key executives who brought Minute Clinic (previously known as Quickmedix) to scale, which was acquired by CVS for $170 million in 2006. For more information, visit the company's website at

mPhase Technologies Inc. (OTC: XDSL)

mPhase Technologies Inc. (OTC: XDSL) is an emerging EV-centric technology company focused on consumer engagement using data analytics and artificial intelligence to create a monetizable link between consumers and retailers at opportunistic times and places. The company is currently building a connected ecosystem of EV charging, 5G internet connectivity and software solutions that optimize consumer engagement within the framework of a SaaS/TaaS model. Branded under the mPower name, this ecosystem will empower the way people shop, dine, fuel and interact with the world to create a richer life experience. The mPower ecosystem is tailored to each individual's tastes and needs, with particular emphasis on empowering tomorrow's green consumer. mPhase also has data driven business units generating recurring revenue outside of its consumer ecosystem, in addition to legacy nanobattery technology and a related patent portfolio that are slated for future development. For more information, visit the company's website at

Nova Leap Health Corp. (TSX.V: NLH)

Nova Leap Health Corp. (TSX.V: NLH) is an acquisitive home health care services company operating in one of the fastest-growing industries in the U.S. and Canada. The company performs a vital role within the continuum of care with an individual and family centered focus, particularly those requiring dementia care. Nova Leap achieved the number 10 ranking in the 2019 TSX Venture 50(TM) in the clean technology & life sciences sector. The company is geographically diversified, with operations in six different U.S. states (Vermont, New Hampshire, Massachusetts, Rhode Island, Oklahoma and Ohio), as well as Nova Scotia, Canada. For more information, visit the company's website at

Novus Acquisition and Development Corp. (OTC: NDEV)

Novus Acquisition and Development Corp. (OTC: NDEV), through subsidiary WCIG Insurance, provides health insurance and related insurance solutions within the wellness and medical marijuana industries in states where legal programs exist. Novus has developed its infrastructure within many lines of the insurance business, such as health, property & casualty, life, accident and fixed annuities. Novus' medical cannabis benefits package will work as outside developers and will not cultivate, handle, transport grow, extract, dispense, put up for sale, put on the market, vend, deliver, supply, circulate or trade cannabis or any substances that violate the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. For more information, visit the company's website at

Petros Pharmaceuticals Inc. (NASDAQ: PTPI)

Petros Pharmaceuticals Inc. (NASDAQ: PTPI) is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring and commercializing innovative therapeutics for men's health issues, including, but not limited to, erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders. In a continued effort to expand its portfolio into other underserved segments, Petros Pharmaceuticals recently executed a definitive global exclusive licensing agreement for a novel and patented topical formulation candidate for the treatment of Peyronie's disease. For more information, visit the company's website at

Polypid Ltd. (NASDAQ: PYPD)

PolyPid Ltd. (NASDAQ: PYPD) is a late-stage biopharma company aiming to improve surgical outcomes through locally administered, controlled, extended-release therapeutics. PolyPid's proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with medications, enables precise delivery of drugs at effective release rates, over durations ranging from several days to months. PolyPid's lead product candidate D-PLEX 100 is in Phase 3 clinical trials for the prevention of sternal and abdominal surgical site infections (SSIs). For more information, visit the company's website at

ProPhase Labs Inc. (NASDAQ: PRPH)

ProPhase Labs Inc. (NASDAQ: PRPH) is a diversified medical science and technology company with deep experience with OTC consumer health care products and dietary supplements. The company is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer health care products and dietary supplements in the United States. This includes the development and marketing of dietary supplements under the TK Supplements brand. The company is also developing ProPhase Diagnostics Inc. ("ProPhase Diagnostics") to offer COVID-19 and other Respiratory Pathogen Panel (RPP) molecular tests. Prophase Labs also continues to actively pursue strategic investments and acquisition opportunities for other companies, technologies and products inside and outside the consumer products industry. For more information, visit the company's website at

Quipt Home Medical Corp. (NASDAQ: QIPT) (TSX.V: QIPT)

Quipt Home Medical Corp. (NASDAQ: QIPT) (TSX.V: QIPT) provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States health care market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The company's organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services and making life easier for the patient. For more information, visit the company's website at


RESAAS Services Inc. (TSX.V: RSS) (OTCQB: RSASF) is a technology platform that enables real estate brokerages, franchises and associations to bring real-time communication, new business opportunities and unique data to their agents on a global basis. RESAAS has propelled the real estate market into the technology space by taking unique industry data and using it to streamline and modernize the way agents can work within their own regions and at a global scale. RESAAS uses its unique real estate data, entered directly by agents, REALTORS® and brokers themselves, to deliver business intelligence to global real estate organizations. In the 10 years RESAAS has been operating, it has become one of the real estate industry's go-to-destinations for international referral business. For more information, visit the company's website at

Resonant Inc. (NASDAQ: RESN)

Resonant Inc. (NASDAQ: RESN) is transforming the market for RF front-ends (RFFE) by disrupting the RFFE supply chain through the delivery of solutions that leverage its Infinite Synthesized Network (ISN) software tools platform, capitalize on the breadth of its IP portfolio, and are delivered through its services offerings. In a market that is critically constrained by limited designers, tools and capacity, Resonant addresses these critical problems by providing customers with ever increasing design efficiency, reduced time to market and lower unit costs. Customers leverage Resonant's disruptive capabilities to design cutting edge filters and modules, while capitalizing on the added stability of a diverse supply chain through Resonant's fabless ecosystem. For more information, visit the company's website at

Rockhaven Resources Ltd. (TSX.V: RK)

Rockhaven Resources Ltd. (TSX.V: RK) is a well-funded explorer focused on the exploration and development of its 100%-owned, camp-scale Klaza Property, which hosts the Klaza Deposit and numerous lightly explored exploration targets. The Klaza Deposit has indicated mineral resources of 4.5Mt containing 686,000 oz gold and 14 million oz silver at grades of 4.8g/t gold and 98g/t silver, and inferred mineral resources of 5.7Mt containing 507,000 oz gold and 13.9 million oz silver at grades of 2.8g/t gold and 76g/t silver. An updated Preliminary Economic Assessment of the Klaza deposit completed in 2020 returned a Post-Tax NPV (5%) of C$378 million and an IRR of 37%, using $1,450/oz gold and $17/oz silver. For more information, visit the company's website at

Rritual Superfoods Inc. (CSE: RSF) (OTCQB: RRSFF)

Rritual Superfoods Inc. (CSE: RSF) (OTCQB: RRSFF) is a fast-growing functional superfood company that creates natural wellness products which support a holistic approach to a healthy lifestyle. The company is poised to dominate a segment where demand and sales are growing exponentially. Under the executive leadership with over 100 years of CPG pedigree, Rritual has launched distribution to major retailers and is positioning itself as a leader in the functional health and wellness industry as a superfood platform. Rritual markets organic wellness products in the United States through initial retail rollout which includes over 10,000 points of sale and through

Safehold Inc. (NYSE: SAFE)

Safehold Inc. (NYSE: SAFE) is revolutionizing real estate ownership by providing a new and better way for owners to unlock the value of the land beneath their buildings. Through its modern ground lease capital solution, Safehold helps owners of high quality multifamily, office, industrial, hospitality and mixed-use properties in major markets throughout the United States generate higher returns with less risk. The company, which is taxed as a real estate investment trust (REIT) and is managed by its largest shareholder, iStar Inc., seeks to deliver safe, growing income and long-term capital appreciation to its shareholders. For more information, visit the company's website at

Sigyn Therapeutics Inc. (OTC: SIGY)

Sigyn Therapeutics Inc. (OTC: SIGY) is focused on a significant unmet need in global health; the treatment of life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome. The annual market opportunity exceeds $20 billion. Sigyn Therapy™ is a multifunctional blood purification technology designed to mitigate the Cytokine Storm that underlies Sepsis (the #1 cause of in-hospital deaths) and other high-mortality inflammatory disorders commonly induced by bacterial and viral pathogens. To overcome the limitations of previous therapies, Sigyn Therapy addresses the source of inflammation (viral pathogens, bacterial toxins) in concert with the broad-spectrum depletion of inflammatory cytokines from the bloodstream. Additionally, the device establishes a therapeutic strategy to target CytoVesicles that transport inflammatory cargos throughout the circulatory system. For more information, visit the company's website at

SPI Energy Co. Ltd. (NASDAQ: SPI)

SPI Energy Co. Ltd. (NASDAQ: SPI) is a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions for business, residential, government, logistics and utility customers and investors. The company provides a full spectrum of EPC services to third-party project developers, as well as develops, owns and operates solar projects that sell electricity to the grid in multiple countries, including the U.S., the U.K., Greece, Japan and Italy. The company has its U.S. headquarters in Santa Clara, California and maintains global operations in Asia, Europe, North America and Australia. SPI is also targeting strategic investment opportunities in green industries such as battery storage and charging stations. For more information, visit the company's website at

TFF Pharmaceuticals Inc. (NASDAQ: TFFP)

TFF Pharmaceuticals Inc. (NASDAQ: TFFP) is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform. Early testing confirms that the TFF platform can significantly improve the solubility and absorption of poorly water-soluble drugs, a class of drugs that comprises approximately one-third of the major pharmaceuticals worldwide, thereby improving their pharmacokinetics. TFF Pharmaceuticals has two lead drug candidates: Voriconazole Inhalation Powder and Tac-Lac Inhalation Powder. The company plans to add to this pipeline by collaborating with large pharmaceutical partners. The TFF Platform is protected by 42 patents issued or pending in the U.S. and internationally. For more information, visit the company's website at

The Glimpse Group Inc. (NASDAQ: VRAR)

The Glimpse Group Inc. (NASDAQ: VRAR) is a diversified virtual and augmented reality platform company, comprised of multiple VR and AR software & services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry. Glimpse's unique business model simplifies challenges faced by VR/AR companies and creates a robust ecosystem, while simultaneously providing investors an opportunity to invest directly into the emerging VR/AR industry via a diversified platform. For more information, visit the company's website at

Thermal Energy International Inc. (TSX.V: TMG) (OTC: TMGEF)

Thermal Energy International Inc. (TSX.V: TMG) (OTC: TMGEF) is an established global supplier of proprietary, proven energy efficiency and emissions reduction solutions to the industrial and institutional sectors. It saves customers money and improves their bottom lines by reducing their fuel use and cutting their carbon emissions. The company's customers include many Fortune 500 and other leading multinational companies across a wide range of industry sectors. Thermal Energy is a fully accredited professional engineering firm, and, by providing a unique mix of proprietary products together with process, energy, and environmental engineering expertise, it is able to deliver unique turnkey projects with significant financial and environmental benefits for its customers. For more information, visit the company's website at

Thunderbird Entertainment Group Inc. (TSX.V: TBRD) (OTCQX: THBRF)

Thunderbird Entertainment Group Inc. (TSX.V: TBRD) (OTCQX: THBRF) is a Vancouver-based multi-platform entertainment company with offices in Vancouver, Los Angeles, Toronto and Ottawa. Thunderbird creates scripted, unscripted and animated programming for global digital platforms, as well as Canadian and International broadcasters. The company develops, produces, and distributes animated, factual and scripted content through its various divisions, including Atomic Cartoons, Great Pacific Television and scripted divisions. For more information, visit the company's website at

Timber Pharmaceuticals Inc. (NYSE American: TMBR)

Timber Pharmaceuticals Inc. (NYSE American: TMBR) is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. The company's investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing and control) and safety profiles. The company is initially focused on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis (CI), facial angiofibromas (FAs) in tuberous sclerosis complex (TSC) and localized scleroderma. For more information, visit the company's website at

Titanium Healthcare Inc.

Titanium Healthcare Inc. has created health care the way its team wants it for their own families. The company does this by thoughtfully applying the highest quality, compassionate medical staff with the best technology to provide patients with extraordinary health care. The company's medical team is here to provide that extra layer of care that some patients need. Titanium also has a team of incredible Care Coordinators to take care of those who need extra help and assistance. For more information, visit the company's website at

Urbanimmersive Inc. (TSX.V: UI) (OTCQB: UBMRF)

Urbanimmersive Inc. (TSX.V: UI) (OTCQB: UBMRF) is a SaaS business management solution that provides mission-critical solutions to visual content providers serving the real estate residential, commercial, construction and local business markets. Urbanimmersive's platform helps customers increase operational productivity and deliver the full potential of visual content creations through leading-edge website builder tools, AI-backed image indexing, robust file transfer systems and interactive visual technology solutions. The firm's core technology is a 3D emulator powered by a visual content recognition post-production algorithm that delivers online and offline alternatives to traditional 3D engines for the creation of immersive digital environments. For more information, visit the company's website at

Vallon Pharmaceuticals Inc. (NASDAQ: VLON)

Vallon Pharmaceuticals Inc. (NASDAQ: VLON) is a clinical-stage biopharmaceutical company, headquartered in Philadelphia, Pennsylvania. The company is focused on the development of new medications to help patients with central nervous system (CNS) disorders. The company's lead investigational product candidate, ADAIR, is a novel abuse deterrent formulation of amphetamine immediate release being developed for the treatment of ADHD and narcolepsy. For more information, visit the company's website at

VersaBank (TSX: VB)

VersaBank (TSX: VB) is a Canadian Schedule I chartered bank that became the world's first fully digital financial institution when it adopted its highly efficient business-to-business model using its proprietary state-of-the art financial technology to profitably address underserved segments of the Canadian banking market. VersaBank obtains all of its deposits and provides the majority of its loans and leases electronically, with innovative deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, VersaBank established wholly owned, Washington, D.C.-based subsidiary DRT Cyber to pursue significant large-market opportunities in cyber security and develop innovative solutions to address the rapidly growing volume of cyber threats challenging financial institutions, multi-national corporations and government entities on a daily basis. For more information, visit the company's website at

Vertical Capital Income Fund (NYSE: VCIF)

Vertical Capital Income Fund (NYSE: VCIF) is a closed-end fund that primarily invests in residential whole mortgage loans and residential whole loans secured by deeds of trust. The investment objective of the fund is to seek income. VCIF is different from other funds that participate in the U.S. residential mortgage market, because it does not purchase tranches of residential mortgage-backed securities. This fact makes VCIF part of a small minority of traded funds and therefore a unique investment opportunity. VCIF has a long track record of providing income via routine monthly distributions and is managed by Oakline Advisors LLC. For more information, visit the company's website at

Victory Square Technologies Inc (CSE: VST) (OTCQX: VSQTF)

Victory Square Technologies Inc (CSE: VST) (OTCQX: VSQTF) builds, acquires and invests in promising startups, then provides the senior leadership and resources needed for fast-track growth. VST's sweet spot is cutting-edge tech that's shaping the fourth Industrial Revolution. The company's portfolio consists of 28 global next generation tech companies in key sectors including: the Creator Economy, Digital Health, Gaming, Web 3.0, VR/AR and Green Tech. For more information, visit the company's website at

Vivos Therapeutics Inc. (NASDAQ: VVOS)

Vivos Therapeutics Inc. (NASDAQ: VVOS) is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have been used to treat over 15,000 patients worldwide by more than 1,100 trained dentists. Combining technologies and protocols that alter the size, shape and position of the tissues of a patient's upper airway, the Vivos System opens airway space and can significantly reduce symptoms and conditions associated with mild-to-moderate OSA. The Vivos System has been shown to significantly lower Apnea Hypopnea Index scores and improve other conditions associated with OSA. For more information, visit the company's website at

VolitionRx Ltd. (NYSE American: VNRX)

VolitionRx Ltd. (NYSE American: VNRX) is a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients, but also to improve their quality of life. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition is primarily focused on human diagnostics but also has a subsidiary focused on animal diagnostics. For more information, visit the company's website at

ZEN Graphene Solutions Ltd. (TSX.V: ZEN) (OTC: ZENYF)

ZEN Graphene Solutions Ltd. (TSX.V: ZEN) (OTC: ZENYF) is a nanotechnology company developing and commercializing next-gen healthcare solutions in the areas of prevention, detection and treatment. ZEN is currently focused on commercializing ZENGuardTM, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology. For more information, visit the company's website at

ZIVO Bioscience Inc. (NASDAQ: ZIVO)

ZIVO Bioscience Inc. (NASDAQ: ZIVO) is a Michigan-based biotech/agtech company engaged in the investigation of the health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures, and the development of natural bioactive compounds for use as dietary supplements and food ingredients, as well as biologically derived and synthetic candidates for medicinal and pharmaceutical applications in humans and animals, specifically focused on the general benefits of autoimmune and inflammatory response modulation. For more information, visit the company's website at

Let's get started.

Interested in a live, online demonstration? Schedule a date and time that works for you.

Schedule a LIVE Demo

Questions about IBN and our solutions? Call or send us an email.

(310) 299-1717